Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Severe acute respiratory syndrome coronavirus 2-mediated dysregulation of drug processing genes is dependent on pathogenic variants, target site of infection, age, and sex. | Drug Metab Dispos | 2025 | 40966877 | PubTator, text mining | PubMed |
| Investigating the Role of Gene Polymorphisms in Hypertension: Evidence from the Jordanian Population. | Vasc Health Risk Manag | 2025 | 40922904 | PubTator, text mining | PubMed |
| Japan's Perspective on Facilitating Drug Development Through Asian Cooperation in Multi-Regional Clinical Trials: Insights From Regulatory Research. | Clin Transl Sci | 2025 | 40922702 | PubTator, text mining | PubMed |
| Population pharmacokinetics and Monte Carlo-based dosing optimization of trimethoprim-sulfamethoxazole. | Antimicrob Agents Chemother | 2025 | 40899995 | PubTator, text mining | PubMed |
| Impact of Genetic Polymorphisms on the Efficacy and Safety of Isoniazid in Saudi Tuberculosis Patients. | Int J Genomics | 2025 | 40894524 | PubTator, text mining | PubMed |
| Roles of lactylation in lipid metabolism and related diseases. | Cell Death Discov | 2025 | 40849305 | PubTator, text mining | PubMed |
| Mini-review: Human N-acetyltransferase genetic polymorphisms in susceptibility to aromatic amine and alkylaniline genotoxicity. | J Pharmacol Exp Ther | 2025 | 40834652 | PubTator, text mining | PubMed |
| NAT2: A Novel Target in Intrahepatic Cholangiocarcinoma and its Role in Modulating Tumor Behavior. | Clin Med Insights Oncol | 2025 | 40831993 | PubTator, text mining | PubMed |
| An oxidative stress related gene signature predicts prognosis in cholangiocarcinoma. | Discov Oncol | 2025 | 40824414 | PubTator, text mining | PubMed |
| Pharmacokinetics of levosimendan in critically Ill children on extracorporeal membrane oxygenation: a prospective observational study. | Front Pediatr | 2025 | 40809383 | PubTator, text mining | PubMed |
| Residue Variations in Human N‑Acetyltransferase 2 Enzyme Alleles: From Rapid to Slow Acetylation. | ACS Omega | 2025 | 40787317 | PubTator, text mining | PubMed |
| Genetics, epidemiology and management of clubfoot and related disorders. | Genes Dis | 2025 | 40746736 | PubTator, text mining | PubMed |
| A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness. | Front Pharmacol | 2025 | 40741006 | PubTator, text mining | PubMed |
| Editorial: Editor's feature: negative findings in pharmacogenetics and pharmacogenomics volume II. | Front Pharmacol | 2025 | 40735478 | PubTator, text mining | PubMed |
| ESCO2 promotes the proliferation of hepatocellular carcinoma through the PI3K/AKT/ mTOR signaling pathway. | J Cancer | 2025 | 40657363 | PubTator, text mining | PubMed |
| Genomic diversity and structure of prehistoric alpine individuals from the Tyrolean Iceman's territory. | Nat Commun | 2025 | 40645944 | PubTator, text mining | PubMed |
| Follow-up of GSTM1, GSTT1, and NAT2 genotyped patients with knee or hip replacement. | EXCLI J | 2025 | 40630467 | PubTator, text mining | PubMed |
| Anti-tuberculosis drug-induced hepatotoxicity and associated risk factors among patients with pulmonary tuberculosis at a tertiary care hospital in Thailand. | IJID Reg | 2025 | 40547509 | PubTator, text mining | PubMed |
| Contributions of pharmacogenetics to personalized precision therapy of diabetes and hypercholesterolemia. | Gac Med Mex | 2025 | 40532247 | PubTator, text mining | PubMed |
| Pharmacogenetic Study of Anti-TB Drugs in the Native Ancestry Peruvian Population. | Pharmacol Res Perspect | 2025 | 40517315 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=4